<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Atopic Dermatitis</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>

    <h1>Atopic Dermatitis</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->

    <div class="outline2">

      <input type="radio" name="control-2" id="show-2">
      <label for="show-2">Show Outline</label>
      <input type="radio" name="control-2" id="hide-2">
      <label for="hide-2">Hide Outline</label>
      <div class="contents">
        <ol>
          <li><a href="#header-1">Definitions</a></li>
          <li><a href="#header-2">Epidemiology</a></li>
          <li><a href="#header-3">Aetiology</a></li>
          <li><a href="#header-4">Pathophysiology</a></li>
          <li><a href="#header-5">Clinical features</a></li>
          <li><a href="#header-6">Diagnosis</a></li>
          <li><a href="#header-7">Investigation</a></li>
          <li><a href="#header-8">Differential diagnosis</a></li>
          <li><a href="#header-9">Complications</a></li>
          <li><a href="#header-10">Management</a></li>
          <li><a href="#header-11">Course and Prognosis</a></li>
       </ol>
      </div>
     <div>


      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Definitions</a>
          </h2>
        </header>
        <div class='body'>
            <p>The words dermatosis, dermatitis and eczema are frequently used and should not be confused with each other.</p>
            <p><strong>Dermatosis:</strong></p>
            <ul>
              <li>Refers to any diagnosis of the skin.</li>
              <li>Encompasses congenital, inflammatory, neoplastic, and all other skin conditions.</li>
            </ul>
            
            <p><strong>Dermatitis:</strong></p>
            <ul>
              <li>Indicates inflammation of the skin, presenting as erythema alone, erythema with scaling, or the latter with vesiculation and crusting.</li>
            </ul>
            <p><strong><em>Dermatitis Classification</em>:</strong></p>
            <ul>
              <li>Endogenous (Constitutional) Dermatitis: e.g., atopic dermatitis and seborrhoeic dermatitis.</li>
              <li>Exogenous Dermatitis: e.g., contact dermatitis caused by external factors in contact with the skin.</li>
            </ul>

            <p><strong>Eczema (Boiling Over):</strong></p>
            <p>Describes various skin conditions characterized by:</p>
            <ol>
              <li>Erythema and skin swelling.</li>
              <li>Oozing and/or vesiculation.</li>
              <li>Crusting and scaling.</li>
              <li>Lichenification or thickening and evidence of repeated excoriations.</li>
              <li>Post-inflammatory hyperpigmentation and/or hypopigmentation due to inflammation's effect on melanocytes.</li>
              <p>The first 3 stages are of acute eczema, while the latter 2 appear after weeks when the condition becomes chronic.</p>
              <p>All changes can co-exist, progressing independently.</p>
            </ol>
            

            
            <p><strong>Atopic Dermatitis (AD) Definition:</strong></p>
            <p>An inherited, chronic, relapsing pruritic skin condition characterized by xerosis and inflammation. It is associated with various pharmacologic and immunologic abnormalities, including overproduction of specific IgE in response to common environmental antigens.</p>
            <p>The severity ranges from mild to severe, potentially interfering with growth and development in severe cases.</p>
                        
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li> A major cause of morbidity in the western world.</li>
              <li> Exact incidence is challenging to determine due to undiagnosed mild cases.</li>
              <li> Incidence seems to be increasing worldwide.</li>
              <li> AD is more common in highly industrialized nations and the western hemisphere compared to Asia.</li>
              <li>Higher incidences found in immigrants from less prevalent areas to more prevalent areas support the strong environmental influence in pathogenesis.</li>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Aetiology</a>
          </h2>
        </header>
        <div class='body'>
            <h4></h4>
            <ul>
              <li><strong>Unclear Etiology:</strong> The exact etiology of AD remains unclear.</li>
              <li><strong>Genetic and Environmental Factors:</strong> It is believed to be linked to both genetic causes and environmental agents.</li>
              <li><strong>Family History:</strong> There is a strong family history of associated atopic diseases in families of AD patients. Nearly 40% of newly diagnosed patients report a positive family history for AD in at least 1 first-degree relative.</li>
              <li><strong>Prevalence with Affected Parents:</strong> The prevalence of AD in children with 1 affected parent is 60%, rising to nearly 80% for children of 2 affected parents.</li>
              <li><strong>Twin Concordance:</strong> Much higher concordance of AD exists in monozygotic twins (86%) compared to dizygotic twins (21%).</li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathophysiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Hyperactive T Helper Cell 2 (Th2) Theory:</strong> One causative theory is that AD results from a hyperactive T helper cell 2 (Th2) and down-regulation of T helper cell 1 (Th1) activity.</li>
              <li><strong>Role of Cytokines:</strong> Th2 cells normally secrete interleukin (IL)-4, IL-5, and IL-13. IL-4 and IL-13 promote immunoglobulin E (IgE) synthesis from B lymphocytes and activate vascular endothelium. IL-5 enhances eosinophil-mediated responses.</li>
              <li><strong>Elevated Serum IgE and Eosinophilia:</strong> This theory is supported by elevated serum IgE levels and peripheral blood eosinophilia commonly seen in AD patients.</li>
              <li><strong>Cytokine Administration:</strong> Evidence suggests that administration of IL-2 or gamma-interferon, cytokines of the Th1 immune response system, to atopic patients can result in improvement in disease severity.</li>
            </ul>
            
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Clinical Features</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>Typically, the disease presents in early infancy, usually in the <strong>first 6 months of life</strong>.</li>
              <li>There may be a <strong>positive family history</strong>, and a history of <strong>exacerbating factors</strong> may be elicited.</li>
              <li>History of <strong>intense pruritus</strong> and a <strong>chronic relapsing course</strong> of the condition would be prominent.</li>
              <li>The earliest lesions are <strong>erythematous, weepy patches</strong> on the cheeks, with subsequent extension to the remainder of the face, neck, wrists, hands, abdomen, and extensor aspects of the extremities.</li>
              <li>Typical locations of lesions by age:</li>
              <ul>
                <li><strong>Nonmobile infant</strong> - Face and scalp</li>
                <li><strong>Crawling infant</strong> - Extensor surfaces of extremities, trunk, face, and neck</li>
                <li><strong>Older child and adolescent</strong> - Wrists, ankles, antecubital fossae, popliteal fossae, and neck</li>
                <li><strong>Adult</strong> - May be limited to hand and foot eczema</li>
              </ul>
            </ul>
            
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Diagnosis</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Various diagnostic criteria</strong> have been drawn up to enhance the diagnosis of AD.</li>
              <li>The most prominent is that proposed by Hanifin and Rajka (1980) and largely adopted by the American Academy of Allergy, Asthma, and Immunology.</li>
              <li>At least <strong>3 major and 3 minor criteria</strong> must be present to make a diagnosis.</li>
              <li><strong>Major criteria:</strong>
                <ul>
                  <li>Pruritus</li>
                  <li>Typical morphology and distribution (i.e. flexural lichenification and linearity in adults, facial and extensor involvement in infants and young children)</li>
                  <li>Chronic or chronically relapsing dermatitis</li>
                  <li>Personal or family history of atopy (e.g. asthma, allergic rhinitis, conjunctivitis, AD)</li>
                </ul>
              </li>
              <li><strong>Minor criteria:</strong>
                <ul>
                  <li>Xerosis (dry skin)</li>
                  <li>Ichthyosis/palmar hyperlinearity/keratosis pilaris</li>
                  <li>Hand and/or foot dermatitis</li>
                  <li>Cheilitis</li>
                  <li>Nipple eczema</li>
                  <li>Susceptibility to cutaneous infection (e.g. with Staphylococcus aureus, herpes simplex virus [HSV], other viruses, warts, molluscum, dermatophytes)</li>
                  <li>Erythroderma</li>
                  <li>Perifollicular accentuation</li>
                  <li>Pityriasis alba</li>
                  <li>Early age of onset</li>
                  <li>Impaired cell-mediated immunity</li>
                  <li>Recurrent conjunctivitis</li>
                  <li>Orbital darkening</li>
                  <li>Infraorbital fold (e.g. Dennie pleat, Morgan fold)</li>
                  <li>Anterior neck folds</li>
                  <li>Keratoconus</li>
                  <li>Anterior subcapsular cataracts</li>
                  <li>Sensitivity to emotional factors</li>
                  <li>Food intolerance</li>
                  <li>Pruritus with sweating</li>
                  <li>Intolerance of wool</li>
                  <li>White dermographism</li>
                  <li>Immediate type I skin test response</li>
                  <li>Elevated total serum IgE</li>
                  <li>Peripheral blood eosinophilia</li>
                </ul>
              </li>
            </ul>
            

            <h4>The U.K. Working Party‚Äôs Diagnostic Criteria for Atopic Dermatitis</h4>
            <p><strong>Individual must have an itchy skin condition plus three or more of the following:</strong></p>
            <ul>
              <li>History of flexural involvement</li>
              <li>History of asthma/hay fever</li>
              <li>History of a generalized dry skin</li>
              <li>Onset of rash under the age of 2 years</li>
              <li>Visible flexural dermatitis</li>
            </ul>

            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
            <p>The transverse nasal crease (arrows) characteristic of allergic rhinitis. This linear change results from repetitive rubbing of the nose vertically, pushing the tip of the nose cephalad.</p>
            <p>Identifying such a crease in a family member of a patient is a useful feature supporting a positive family history of allergy.</p>
            
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Investigation </a>
          </h2>
        </header>
        <div class='body'>
            <p><em>Definitive laboratory tests are lacking for diagnosing AD.</em></p>
            <p>Elevated serum IgE levels and peripheral blood eosinophilia often occur in individuals with AD.</p>
            <p>Tests for infections that mimic or complicate AD include:</p>
            <ul>
              <li>Tzanck smear for HSV</li>
              <li>Potassium hydroxide (KOH) preparation for dermatophytes</li>
              <li>Gram stain for bacterial infections</li>
            </ul>
            <p>Prick skin testing for common allergens can identify triggers of AD, especially in young children with moderate-to-severe disease, though false-negative and false-positive results are possible in children under 8 years.</p>
            
                       
        </div>
      </section>


      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Differential Diagnosis </a>
          </h2>
        </header>
        <div class='body'>
            <p><strong>AD</strong> is often confused with other skin disorders.</p>
            <p><strong>Seborrheic dermatitis</strong> is the most common condition mistaken for <strong>AD</strong>.</p>
            <p>It typically presents as a <strong>yellow greasy scale</strong> on an <strong>erythematous base</strong>. Unlike <strong>AD</strong>, it is usually <strong>not pruritic</strong> and has an <strong>excellent prognosis</strong>.</p>
            
                   
            <h4>Distinguishing Features Between Infantile Seborrhoeic Dermatitis and Atopic Dermatitis</h4>
            <table class="note-table">
              <tr>
                <th>Features</th>
                <th>Infantine Seborrhoeic Dermatitis</th>
                <th>Atopic Dermatitis</th>
              </tr>
              <tr>
                <td><strong>Age of Onset</strong></td>
                <td><strong>4 ‚Äì 6 weeks (early)</strong></td>
                <td><strong>3 ‚Äì 6 months (late)</strong></td>
              </tr>
              <tr>
                <td><strong>Site involved</strong></td>
                <td><strong>Scalp & Skin fold</strong></td>
                <td><strong>Face</strong></td>
              </tr>
              <tr>
                <td><strong>Pruritus</strong></td>
                <td><strong>Absent</strong></td>
                <td><strong>Present</strong> (notable features)</td>
              </tr>
              <tr>
                <td><strong>Morphology</strong></td>
                <td><strong>‚ÄúBenign‚Äù looking</strong> mildly scaling patches, minimal or no erythema</td>
                <td><strong>‚ÄúAngry‚Äù looking</strong>, active reddish eruption.</td>
              </tr>
              <tr>
                <td><strong>Post infl. Colour</strong></td>
                <td><strong>Hypopigmentation</strong></td>
                <td><strong>Hyperpigmentation</strong></td>
              </tr>
              <tr>
                <td><strong>Prognosis limiting</strong></td>
                <td><strong>Good</strong> and self-resolving within a few weeks</td>
                <td><strong>Poor</strong>, often progresses to childhood</td>
              </tr>
            </table>
            
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Complications </a>
          </h2>
        </header>
        <div class='body'>
            <p><strong>Infections</strong></p>
            <ul>
              <li><strong>During early infancy and childhood</strong>, secondary infection of the lesions of atopic dermatitis with bacterial, fungal, or viral agents is common.</li>
              <li><strong>Staphylococci</strong> and <strong>B-hemolytic streptococci</strong> are the bacterial agents most often recovered from infected lesions.</li>
              <li><strong>Herpes simplex (Kaposi's varicelliform eruption)</strong> is also of particular concern.</li>
            </ul>
            <p><strong>Contact dermatitis</strong></p>
            <ul>
              <li>The <strong>hands of AD patients</strong> are intolerant to irritants like detergents, shampoos, and wet jobs. They are also prone to <strong>nickel hand eczemas</strong>.</li>
            </ul>
            <p><strong>Anaphylactic syndromes</strong></p>
            <ul>
              <li>These patients are prone to <strong>IgE mediated urticaria-anaphylactic syndromes</strong>. Therefore, various injections, penicillin, chloroquine, and horse sera are <strong>best avoided</strong> in these patients.</li>
            </ul>
            <p><strong>Psychological stress</strong></p>
            <p>This usually sets in because of the <strong>resentment from school mates and teachers</strong> who believe in the contagiousness of all skin diseases.</p>
                       
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'>Management </a>
          </h2>
        </header>
        <div class='body'>
            <p>The management of atopic patients is aimed at:</p>
            <ol>
              <li><strong>Suppressing the urge to scratch</strong></li>
              <li><strong>Suppressing inflammation</strong></li>
              <li><strong>Preventing infections</strong> and <strong>prompt treatment of infections</strong>.</li>
              <li><strong>Avoiding other exacerbating factors</strong>.</li>
              <li><strong>Avoiding the complications of treatment</strong>.</li>
              <li><strong>Correcting misconceptions</strong> about the disease.</li>
            </ol>
            <p>Treatment consists of:</p>
            <ul>
              <li><strong>Adequate skin hydration</strong>.</li>
              <li><strong>Avoidance of allergenic precipitants</strong>.</li>
              <li><strong>Topical anti-inflammatory medications</strong>.</li>
              <li><strong>Systemic antihistamines</strong>.</li>
              <li><strong>Antibiotic coverage of secondary infections</strong>.</li>
            </ul>
                    
            <p><strong>One of the most important aspects of therapy</strong> is establishing an honest relationship with the parents, explaining the nature of the disease, and stressing the fact that there is <strong>no cure</strong>.</p>
            <p><strong>Topical corticosteroids</strong> are the mainstay of treatment of AD.</p>
            <p><strong>Topical steroids</strong> should be applied only to areas of acute exacerbations, whereas <strong>emollients</strong> should be used over the remainder of the skin.</p>
            <p>Formulations of steroids in ascending order of occlusiveness are <strong>lotions, creams, gels, and ointments</strong>.</p>
            <p><strong>Systemic corticosteroids</strong> have been used in severe chronic AD, but usage has been limited in the pediatric population because of the risk of <strong>severe adverse effects</strong>.</p>
            <p>In older children and adolescents, treat mild cases of AD with a <strong>low-potency</strong> (class VI or VII) topical steroid <strong>twice a day</strong> to decrease inflammation. Examples include hydrocortisone cream or ointment, 1% and 2.5%.</p>
            <p>For moderate cases of AD, <strong>intermediate-potency steroids</strong> (class III, IV, V) may be used for <strong>brief periods</strong> (&lt;2 wk).</p>
            <p>Class VII steroids on the <strong>face, axillae, groin, and intertriginous areas</strong> because of increased absorption.</p>
            <p>For mild AD in infants, class VI or VII <strong>topical steroids</strong> should be effective. If the infant has more severe AD, a <strong>moderate-potency steroid</strong> can be prescribed for <strong>up to 1 week</strong> and then tapered down to a lower-potency medication for maintenance therapy.</p>
            <p>In general, <strong>infants should not be treated</strong> with <strong>topical steroids</strong> in the high-potency classes.</p>
            <p><strong>Antihistamines</strong> are used to reduce pruritus and serve as sedatives, and mild anxiolytics, e.g. diphenhydramine, hydroxyzine, or doxepin.</p>
            <p><strong>Oral antibiotics</strong> are useful in treating recalcitrant lesions and secondarily infected ones, e.g. <strong>Erythromycin</strong>.</p>
            <p><strong>Coal tar topical preparations</strong> have antipruritic and anti-inflammatory effects. They are effective as <strong>second-line agents</strong> for subacute, chronic, and lichenified AD, e.g. <strong>PsoriGel</strong>, and <strong>Neutrogena T/Derm Tar Emollient</strong>.</p>
            <p>Topically applied <strong>tacrolimus</strong> has proven to be an effective new therapy for AD. It is a <strong>nonsteroidal alternative</strong> that is especially useful when treating facial and intertriginous dermatitis.</p>
            <p>Systemic <strong>cyclosporine</strong> can dramatically <strong>reverse severe flares</strong> of AD.</p>
            
            <p><strong>Ultraviolet radiation -</strong> Ultraviolet light may benefit some patients. Ultraviolet light in the UVB range may provide control and eliminate or markedly reduce the need for steroids.</p>
            <p><strong>Adequate rehydration</strong> preserves the stratum corneum barrier, minimizing the direct effects of irritants and allergens on the skin.</p>
            <p><strong>Lukewarm soaking baths</strong> lasting 20-30 minutes are ideal. Small amounts of bath oils or emulsification agents may be used for added hydration benefits.</p>
            <p><strong>Recommended soaps</strong> are mild and unscented with a neutral pH. Examples include Dove, Oil of Olay, Caress, Camay, Aveeno, and Purpose.</p>
            <p><strong>Baths should be followed</strong> by the immediate application of an occlusive emollient over the entire skin surface to retain moisture in the epidermis.</p>
            <p><strong>Urea, alpha-hydroxy acid, and lactic acid preparations</strong> have also been shown to soften and moisturize dry skin.</p>
            <p><strong>Wet dressings</strong> are very useful for diverse types of atopic dermatitic flares and can be used on dry lichenified lesions to improve hydration and increase the penetration of topical corticosteroids.</p>
            <p><strong>There may be some benefit</strong> in eliminating some common allergenic foods in the diet until after acute flares or introduce them at about 1 -2 yrs when reactivity would have reduced.</p>
            <p><strong>Implement dust mite and mold control measures</strong> for allergic children.</p>
            <p><strong>Wear loose fitting open-weave cotton</strong> or cotton-blend clothing; avoid wool.</p>
            <p><strong>Use a humidifier in the winter</strong> to prevent excessive skin dryness and an air conditioner in the summer to prevent sweating and associated macerative effects on the skin.</p>
            
        </div>
      </section>

      <section id='header-11'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-11'>Course and Prognosis </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Sixty percent</strong> of affected individuals manifest characteristic lesions during the <strong>first year of life</strong>. <strong>Ninety percent</strong> of individuals will be affected by <strong>age 5 yr</strong>.</li>
              <li>The remaining individuals will typically manifest disease during <strong>late childhood or adolescence</strong>. It is <strong>rare for symptoms to begin during adulthood</strong> and should be a clue to question the accuracy of diagnosis.</li>
              <li>The clinical course is <strong>variable and unpredictable</strong>. Some infants and children will have a <strong>mild course with spontaneous remission</strong> by <strong>2‚Äì3 yr of age</strong>. Others will have <strong>more persistent disease with a chronic unremitting course throughout childhood</strong>.</li>
            </ul>
            

            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>

              <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption"></div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption"></div>
              </div>
        </div>
      </section>

      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

      
                <div class="comment">
        <p>Send your comments, corrections, explanations/clarifications and requests/suggestions to our <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">WhatsApp group</a>.</p>
        </div>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The content on this ‚ÄòWebsite‚Äô, including but not limited to text, graphics, images, videos, and other materials, should not be considered as a substitute for formal medical education or clinical training. The creators and operators of this Website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the Website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this Website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>     
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
          <p><a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1">say hiüëã</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
</body>
</html>
 
